Pro Doc Limitee Ranitidine Product Recall (2019-09-24)
- Starting date:
- September 24, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-71063
Last updated: 2019-09-25
A. Ranitidine- 150
B. Ranitidine- 300
Reason
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA).
Depth of distribution
Wholesalers, Healthcare Establishments, Retailers
Affected products
A. Ranitidine- 150
DIN, NPN, DIN-HIM
DIN 00740748
Dosage form
Tablet
Strength
Ranitidine hydrochloride 150 mg
Lot or serial number
All lots
Companies
- Recalling Firm
-
Pro Doc Limitee
2925 Boulevard Industriel
Laval
H7L 3W9
Quebec
CANADA
- Marketing Authorization Holder
-
Pro Doc Limitee
2925 Boulevard Industriel
Laval
H7L 3W9
Quebec
CANADA
B. Ranitidine- 300
DIN, NPN, DIN-HIM
DIN 00740756
Dosage form
Tablet
Strength
Ranitidine hydrochloride 300 mg
Lot or serial number
All lots
Companies
- Recalling Firm
-
Pro Doc Limitee
2925 Boulevard Industriel
Laval
H7L 3W9
Quebec
CANADA
- Marketing Authorization Holder
-
Pro Doc Limitee
2925 Boulevard Industriel
Laval
H7L 3W9
Quebec
CANADA